Cambridge Healthtech Institute 제1회

Digital Therapeutics
(디지털 치료제)

근거에 기반한 임상적 검증을 거친 디지털 치료제와 의료의 통합

2020년 6월 2일-4일


디지털 치료제를 테마로 한 이 컨퍼런스 프로그램에서는 제약회사 및 IT 기업, 주요 연구기관 및 의료기관, 규제기관, 건강보험 등의 조직에 소속된 업계 리더가 한자리에 모여 디지털 치료제를 환자에게 제공하기 위한 방안 등에 대해 논의합니다.

아젠다(잠정판)

6월 2일(화)

전체 세션:의료 분야에서의 디지털 트랜스포메이션

Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions

Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health

Driving Digital Transformation Success

Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center

Talk Title to be Announced

Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare

Delivering Digital Health in a Consumer Health World

Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens

The Future of Health has Arrived: The Rise of Smart Health Communities

Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

처방전에 기반한 디지털 치료제를 위한 제휴 전략

Prescription DTx

Alex Waldron, Chief Strategy Officer, Pear Therapeutics

PANEL DISCUSSION: Partnering Strategies for Digital Therapeutics

Moderator: Alex Waldron, Chief Strategy Officer, Pear Therapeutics


전체 세션:다른 전문 영역 간 제휴:디지털 헬스에 대한 통합화 접근

Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital

Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity

 

6월 3일(수)

전체 세션:디지털 헬스 분야의 기술 혁신

PANEL DISCUSSION: Investing in Digital Health Innovation

Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists:
David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

Delivering Global Comprehensive Virtual Care at Scale

Lewis Levy, MD, FACP, CMO, Teladoc

 

Additional Company Presentations to be Announced

질병 관리와 처방약 복약 준수를 위한 디지털 컴패니언(DIGITAL COMPANIONS)

Digital Therapeutics as Companion to Pharmaceuticals: Lessons Learned and Perspectives

Pierre Leurent, CEO, Voluntis

 

Additional Presentations to be Announced

디지털 치료제의 상업화 전략:시장 참여와 가치 모델

Partnerships to Commercialize Digital Therapeutics

Adam Kaufman, PhD, President & CEO, Canary Health

Challenges and Potential Solutions in the Commercialization of Digital Therapeutics

David O'Reilly, Chief Platform Officer, Proteus Digital Health

PANEL DISCUSSION: Commercialization Strategies for Digital Therapeutics

Moderator: Adam Kaufman, PhD, President & CEO, Canary Health

 

6월 4일(목)

만성질환용 근거 기반 맞춤형 디지털 치료제

Beyond DTx - Engaging the Patient Holistically to Optimize Outcomes

Olivier Jarry, Chief Commercial Officer, President, DarioHealth Corp

Digital Therapeutics for Mental Health: Improving Outcomes, Access and Scale for Mental Healthcare

Ken Cahill, CEO, SilverCloud Health

전체 세션:근거 기반 디지털 의료

Talk Title to be Announced

Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

PANEL DISCUSSION: Real World Impact of Digital Medicine

Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai



* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English



Catalog Download
Catalog


메일링 서비스